Your browser doesn't support javascript.
loading
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Tuttle, Katherine R; Brosius, Frank C; Cavender, Matthew A; Fioretto, Paola; Fowler, Kevin J; Heerspink, Hiddo J L; Manley, Tom; McGuire, Darren K; Molitch, Mark E; Mottl, Amy K; Perreault, Leigh; Rosas, Sylvia E; Rossing, Peter; Sola, Laura; Vallon, Volker; Wanner, Christoph; Perkovic, Vlado.
Afiliação
  • Tuttle KR; Providence Health Care and University of Washington School of Medicine, Spokane, WA. Electronic address: katherine.tuttle@providence.org.
  • Brosius FC; University of Arizona College of Medicine, Tucson, AZ.
  • Cavender MA; University of North Carolina School of Medicine, Chapel Hill, NC.
  • Fioretto P; Department of Medicine, University of Padua, Italy.
  • Fowler KJ; The Voice of the Patient, Inc, Elmhurst, IL.
  • Heerspink HJL; University of Groningen, Groningen, the Netherlands.
  • Manley T; National Kidney Foundation, New York, NY.
  • McGuire DK; University of Texas Southwestern Medical Center, Dallas, TX.
  • Molitch ME; Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern, University Feinberg School of Medicine, Chicago, IL.
  • Mottl AK; University of North Carolina School of Medicine, Chapel Hill, NC.
  • Perreault L; University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Rosas SE; Joslin Diabetes Center and Harvard Medical School, Boston, MA.
  • Rossing P; Steno Diabetes Center Copenhagen, Gentofte; University of Copenhagen, Copenhagen, Denmark.
  • Sola L; University of the Republic, Montevideo, Uruguay.
  • Vallon V; University of California-San Diego, La Jolla, CA.
  • Wanner C; Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.
  • Perkovic V; George Institute for Global Health, UNSW Sydney, Australia.
Am J Kidney Dis ; 77(1): 94-109, 2021 01.
Article em En | MEDLINE | ID: mdl-33121838

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Risco Ajustado / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Risco Ajustado / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article